GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Grey Wolf Animal Health WOLF.V · CAD

N/A · TSX Venture · 🇨🇦 Canada

Compare

1.68

—

Close of 6 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CAD, from our data supplier.

FY2025

Revenue

C$35.8m

FY2021FY2025

Net income

C$1.7m

FY2021FY2025

Free cash flow

C$3.3m

FY2021FY2025

Shareholders' equity

C$30.6m

FY2021FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021
RevenueC$35.8mC$26.8mC$25.4mC$22.6mC$13.1m
Gross profitC$19.1mC$13.8mC$12.8mC$11.6mC$7.1m
Research and developmentC$149,576C$98,261C$73,810C$59,497C$52,252
Operating incomeC$4.1mC$1.9mC$1.6m—C$70,410
Net incomeC$1.7mC$704,668C$609,582C$2.5m−C$968,939
Diluted earnings per share0.050.020.020.08-0.03

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Total assetsC$64.5mC$65.6mC$41.4mC$39.3mC$36.2m
Total liabilitiesC$34.0mC$36.8mC$16.3mC$15.1mC$32.2m
DebtC$22.9mC$24.8mC$8.1mC$9.1mC$10.0m
Shareholders' equityC$30.6mC$28.8mC$25.1mC$24.2mC$4.1m
Shares outstanding34m34m31m31m31m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021
Cash from operationsC$3.8mC$1.7mC$2.4m−C$710,282C$2.1m
Capital spending−C$519,106−C$534,024−C$284,441−C$53,756−C$14,995
Free cash flowC$3.3mC$1.2mC$2.1m−C$764,038C$2.1m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueC$10.6mC$8.8mC$9.0mC$9.3mC$9.5mC$7.9mC$6.7mC$6.9m
Gross profitC$5.9mC$4.7mC$4.7mC$4.9mC$5.3mC$4.2mC$3.4mC$3.5m
Operating incomeC$1.2mC$683,210C$824,344C$1.2mC$1.5mC$521,199−C$211,729C$802,191
Net incomeC$502,752C$145,265C$329,286C$548,976C$751,230C$27,248−C$501,102C$502,151
Diluted earnings per share0.010.000.010.020.020.00-0.010.02
Cash from operations—C$1.0mC$1.0mC$1.0m—C$1.0mC$1.0m—
Total assetsC$64.8mC$64.4mC$64.5mC$65.4mC$64.8mC$65.0mC$65.6mC$40.7m
DebtC$22.0mC$22.4mC$22.9mC$23.4mC$23.9mC$24.3mC$24.8mC$7.4m
Shareholders' equityC$31.7mC$31.0mC$30.6mC$30.2mC$29.6mC$28.9mC$28.8mC$26.3m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue16.5%——
Net income-13.3%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin52.4%51.7%——
Operating margin9.5%———
Net margin3.8%5.0%——

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings27.253.937.79.5-29.5
Price to sales1.31.40.91.12.2

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 16.6667-to-1 reverse split · 23 Nov 2022

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.